Panbela Therapeutics (PBLA) Institutional Ownership → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free PBLA Stock Alerts $0.44 -0.05 (-10.11%) (As of 01:06 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Panbela Therapeutics (NASDAQ:PBLA)CurrentInstitutional OwnershipPercentage4.37%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$510.10MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$12.83M Get PBLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Panbela Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PBLA Institutional Buying and Selling by Quarter Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Panbela Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2023Walleye Capital LLC94,536$217K0.0%N/A16.881% 8/15/2023Hudson Bay Capital Management LP76,000$175K0.0%-78.6%13.571% 5/19/2023Anson Funds Management LP163,024$72K0.0%N/A0.971% 5/16/2023Hudson Bay Capital Management LP355,000$157K0.0%N/A2.115% 5/16/2023CVI Holdings LLC394,901$175K0.1%N/A2.352% 5/16/2023Sabby Management LLC426,363$189K0.2%N/A2.540% Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2023Altium Capital Management LP335,324$148K0.1%N/A1.998% 5/15/2023Anson Funds Management LP163,024$72K0.0%N/A0.971% 5/12/2023HRT Financial LP68,549$30K0.0%N/A0.408% 11/15/2022Vanguard Group Inc.222,303$60K0.0%N/A0.701% 11/14/2022Armistice Capital LLC2,176,809$588K0.0%N/A5.324% 11/10/2022UBS Group AG190,493$51K0.0%+46,589.5%0.466% 11/2/2022Clear Street LLC110,500$30K0.0%N/A0.532% 4/7/2022Fieldpoint Private Securities LLC62,621$132K0.0%-33.7%0.466% 2/14/2022Murchinson Ltd.136,753$238K0.0%-8.8%1.018% 1/24/2022Fieldpoint Private Securities LLC94,521$164K0.0%-31.8%0.704% 11/12/2021Fieldpoint Private Securities LLC138,660$301K0.1%-5.4%1.033% 11/9/2021BlackRock Inc.29,359$64K0.0%+22.2%0.219% 8/16/2021Warberg Asset Management LLC11,567$33K0.0%N/A0.086% 8/13/2021Murchinson Ltd.150,000$425K0.2%N/A1.117% 8/13/2021Vanguard Group Inc.217,198$615K0.0%+941.8%1.618% 8/12/2021Fieldpoint Private Securities LLC146,500$359K0.1%-20.4%1.091% 8/11/2021CVI Holdings LLC41,667$118K0.0%N/A0.310% 8/6/2021Buckingham Strategic Wealth LLC24,927$71K0.0%N/A0.186% 5/19/2021Squarepoint Ops LLC15,538$61K0.0%N/A0.154% 5/18/2021Verition Fund Management LLC20,000$79K0.0%-67.0%0.198% 5/17/2021Ikarian Capital LLC345,013$1.36M0.0%N/A3.420% 4/23/2021Fieldpoint Private Securities LLC184,000$727K0.2%N/A1.824% 2/18/2021Verition Fund Management LLC60,606$216K0.0%N/A0.628% 2/17/2021Worth Venture Partners LLC21,794$78K0.1%N/A0.226% 2/13/2021Essex Investment Management Co. LLC63,079$225K0.0%N/A0.654% 2/1/2021Brand Asset Management Group Inc.57,144$203K0.1%N/A0.592% (Data available from 1/1/2016 forward) PBLA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PBLA shares? During the previous two years, 11 institutional investors and hedge funds held shares of Panbela Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($588K), Walleye Capital LLC ($217K), Sabby Management LLC ($189K), Hudson Bay Capital Management LP ($175K), CVI Holdings LLC ($175K), Altium Capital Management LP ($148K), and Anson Funds Management LP ($72K).Learn more on PBLA's institutional investors. What percentage of Panbela Therapeutics stock is owned by institutional investors? 4.37% of Panbela Therapeutics stock is owned by institutional investors. Learn more on PBLA's institutional investor holdings. Which institutional investors have been buying Panbela Therapeutics stock? Of the 11 institutional investors that purchased Panbela Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($2.18M), Sabby Management LLC ($426.36K), CVI Holdings LLC ($394.90K), Hudson Bay Capital Management LP ($355K), Altium Capital Management LP ($335.32K), Anson Funds Management LP ($326.05K), and Vanguard Group Inc. ($222.30K). How much institutional buying is happening at Panbela Therapeutics? Institutional investors have bought a total of 4,700,418 shares in the last 24 months. This purchase volume represents approximately $18.02B in transactions. Which Panbela Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Panbela Therapeutics stock in the last 24 months: Hudson Bay Capital Management LP ($279K). How much institutional selling is happening at Panbela Therapeutics? Institutional investors have sold a total of 279,000 shares in the last 24 months. This volume of shares sold represents approximately $12.83M in transactions. Related Companies: Dermata Therapeutics Institutional Ownership InMed Pharmaceuticals Institutional Ownership Qualigen Therapeutics Institutional Ownership Galmed Pharmaceuticals Institutional Ownership Lucy Scientific Discovery Institutional Ownership GRI Bio Institutional Ownership Bio-Path Institutional Ownership Clearmind Medicine Institutional Ownership NeuBase Therapeutics Institutional Ownership Salarius Pharmaceuticals Institutional Ownership This page (NASDAQ:PBLA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy Sykes1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.